Perelman School of Medicine, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Ophthalmology, Cairo University, Cairo, Egypt.
Retina. 2024 Jul 1;44(7):1242-1250. doi: 10.1097/IAE.0000000000004081.
To determine factors associated with visual and anatomic outcomes of suprachoroidal hemorrhage in studies published between 1990 and 2022.
Individual participant data systematic review. The protocol was prospectively registered on Open Science Framework ( https://osf.io/69v3q/ ). PubMed, EMBASE, Web of Science, and Google Scholar were searched for peer-reviewed studies of suprachoroidal hemorrhage with ≥3 patients published between January 1, 1990, and September 1, 2022. The primary outcome was the change in logarithm of the minimum angle of resolution visual acuity from the time of suprachoroidal hemorrhage diagnosis to last follow-up.
Four hundred thirteen eyes from 49 studies were included, with mean (SD) age 60.8 (22.4) years and mean (SD) follow-up of 13.8 (12.6) months. Among 145 eyes with at least 6 months of follow-up, the mean (SD) gain in visual acuity was -0.98 (0.89) logarithm of the minimum angle of resolution. In multivariable regression, treatment with systemic steroids was associated with greater improvement in logarithm of the minimum angle of resolution visual acuity (adjusted mean [SE] -1.29 [0.09] vs. -0.16 [0.30] for no systemic steroids; P < 0.001) and greater odds of achieving anatomic success (adjusted OR 10.59, 95% confidence interval 2.59-43.3; P = 0.001).
The use of systemic steroids was associated with better visual and anatomic outcomes for suprachoroidal hemorrhage.
确定 1990 年至 2022 年期间发表的研究中与脉络膜上腔出血的视觉和解剖结果相关的因素。
个体参与者数据系统评价。该方案在开放科学框架(https://osf.io/69v3q/)上进行了前瞻性注册。检索了 1990 年 1 月 1 日至 2022 年 9 月 1 日期间发表的、有≥3 例脉络膜上腔出血患者的同行评审研究,以评估脉络膜上腔出血的视觉和解剖结果。主要结局是从脉络膜上腔出血诊断到最后一次随访时最小分辨角视力对数的变化。
纳入了 49 项研究的 413 只眼,平均(SD)年龄为 60.8(22.4)岁,平均(SD)随访时间为 13.8(12.6)个月。在 145 只至少随访 6 个月的眼中,视力的平均(SD)提高值为-0.98(0.89)对数最小分辨角。在多变量回归中,全身使用皮质类固醇与最小分辨角视力对数的改善更相关(调整后的平均差值[SE]为-1.29[0.09] vs. -0.16[0.30],无全身皮质类固醇治疗;P<0.001),且更有可能获得解剖成功(调整后的比值比 10.59,95%置信区间 2.59-43.3;P=0.001)。
全身使用皮质类固醇与脉络膜上腔出血的视觉和解剖结果更好相关。